Table of Contents
Advances in Endocrinology
Volume 2014, Article ID 973184, 4 pages
http://dx.doi.org/10.1155/2014/973184
Research Article

Is Dopamine an Iatrogenic Disruptor of Thyroid and Cortisol Function in the Extremely Premature Infant?

1Department of Women’s and Children’s Health, Institute of Translational Medicine, University of Liverpool, Liverpool Women’s Hospital, Crown Street, Liverpool L87SS, UK
2Department of Paediatrics, Southport and Ormskirk NHS Trust, Wigan Road, Ormskirk L39 2AZ, UK
3Department of Biochemistry, Alder Hey Children’s Foundation Trust, Eaton Road, Liverpool L12 2AP, UK

Received 6 April 2014; Revised 24 May 2014; Accepted 26 May 2014; Published 4 June 2014

Academic Editor: Wayne Brake

Copyright © 2014 Sze M. Ng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. M. Ng, “Hypothyroxinemia of prematurity: cause, diagnosis and management,” Expert Review of Endocrinology and Metabolism, vol. 3, no. 4, pp. 453–462, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. S. M. Ng, M. A. Turner, C. Gamble et al., “An explanatory randomised placebo controlled trial of levothyroxine supplementation for babies born <28 weeks' gestation: results of the TIPIT trial,” Trials, vol. 14, no. 1, article 211, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Filippi, M. Pezzati, C. Poggi, S. Rossi, A. Cecchi, and C. Santoro, “Dopamine versus dobutamine in very low birthweight infants: endocrine effects,” Archives of Disease in Childhood: Fetal and Neonatal Edition, vol. 92, no. 5, pp. F367–F371, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. I. Seri, T. tulassay, J. Kiszel et al., “Effect of low-dose dopamine infusion on prolactin and thyrotropin secretion in preterm infants with hyaline membrane disease,” Biology of the Neonate, vol. 47, no. 6, pp. 317–322, 1985. View at Google Scholar · View at Scopus
  5. C. Dieguez, S. M. Foord, G. R. Newman et al., “Rat anterior pituitary cells maintained on artificial capillaries: responses of thyrotrophs and lactotrophs to depolarization, TRH and dopamine,” Molecular and Cellular Endocrinology, vol. 37, no. 1, pp. 73–82, 1984. View at Google Scholar · View at Scopus
  6. D. S. Cooper, A. Klibanski, and E. C. Ridgway, “Dopaminergic modulation of TSH and its subunits: in vivo and in vitro studies,” Clinical Endocrinology, vol. 18, no. 3, pp. 265–275, 1983. View at Google Scholar · View at Scopus
  7. M. L. Reuss, N. Paneth, J. A. Pinto-Martin, J. M. Lorenz, and M. Susser, “The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age,” The New England Journal of Medicine, vol. 334, no. 13, pp. 821–827, 1996. View at Publisher · View at Google Scholar · View at Scopus
  8. A. G. van Wassenaer, J. Westera, B. A. Houtzager, and J. H. Kok, “Ten-year follow-up of children born at <30 weeks' gestational age supplemented with thyroxine in the neonatal period in a randomized, controlled trial,” Pediatrics, vol. 116, no. 5, pp. e613–e618, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. G. van den Berghe, F. de Zegher, and P. Lauwers, “Dopamine suppresses pituitary function in infants and children,” Critical Care Medicine, vol. 22, no. 11, pp. 1747–1753, 1994. View at Google Scholar · View at Scopus
  10. L. Filippi, M. Pezzati, A. Cecchi, and C. Poggi, “Dopamine infusion: a possible cause of undiagnosed congenital hypothyroidism in preterm infants,” Pediatric Critical Care Medicine, vol. 7, no. 3, pp. 249–251, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. F. de Zegher, G. van den Berghe, H. Devlieger, E. Eggermont, and J. D. Veldhuis, “Dopamine inhibits growth hormone and prolactin secretion in the human newborn,” Pediatric Research, vol. 34, no. 5, pp. 642–645, 1993. View at Google Scholar · View at Scopus
  12. G. Parry, J. Tucker, and W. Tarnow-Mordi, “CRIB II: an update of the clinical risk index for babies score,” The Lancet, vol. 361, no. 9371, pp. 1789–1791, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. F. L. R. Williams, S. A. Ogston, H. Van Toor, T. J. Visser, and R. Hume, “Serum thyroid hormones in preterm infants: associations with postnatal illnesses and drug usage,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 11, pp. 5954–5963, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. S. M. Ng, D. Anand, and A. M. Weindling, “High versus low dose of initial thyroid hormone replacement for congenital hypothyroidism,” Cochrane Database of Systematic Reviews, no. 1, 2009. View at Google Scholar · View at Scopus
  15. S. M. Foord, J. R. Peters, C. Dieguez, M. F. Scanlon, and R. Hall, “Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin,” Endocrinology, vol. 112, no. 5, pp. 1567–1577, 1983. View at Google Scholar · View at Scopus
  16. F. L. R. Williams, T. J. Visser, and R. Hume, “Transient hypothyroxinaemia in preterm infants,” Early Human Development, vol. 82, no. 12, pp. 797–802, 2006. View at Publisher · View at Google Scholar · View at Scopus